This week’s issue of the Lancet “has an HIV theme ahead of the International AIDS Society meeting in Washington, D.C., … on July 22-27,” a Lancet editorial states, noting, “The issue of antiretrovirals for prevention, specifically pre-exposure prophylaxis, is presently under intense debate.” According to the editorial, “Two articles present further efforts to make treatment better and improve patients’ adherence,” and “[a] third article shows the benefits of antiretrovirals when given to either mothers or infants to prevent HIV transmission via breastfeeding” (6/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.